Longevium is a Dubai-based longevity healthcare company that raised $7 million in its first funding round to build an AI-powered Longevity Research Laboratory. The lab, under construction at Dubai Science Park, is scheduled to open in the fourth quarter of 2026 and will function as a research and development centre rather than a clinical site. The company plans to combine artificial intelligence, biomedical research and clinical expertise to create tools for predicting health risks, measuring biological ageing and extending healthy lifespans. Key development areas include AI-powered digital twins for personalised treatment simulation, regenerative medicine and advanced cell therapies aimed at restoring organ function. Longevium also intends to pursue robotic diagnostic technologies (including swallowable imaging capsules and AI-powered skin cancer scanners) and explore noble gas therapies such as xenon, argon, helium and krypton. The newly raised funds will finance the laboratory build-out and support the company’s planned diagnostics, longevity technology research and clinical research programmes.

Total raised

$7M

Funding rounds

1

Latest round

Seed

Latest activity

Aug 2026